Pediatric Rare Disease Studies: Patient-Centric Approaches,

Toronto, ON (PRWEB) August 24, 2022 -- The phrase “patient-centricity” can mean many things but at heart it means designing a treatment, clinical trial, or

Related Keywords

Scott Schliebner , Alison Sampson , Clinical Development Services Head Of Rare Diseases , Honeycomb Worldwide Inc , Senior Vice President , Clinical Development Services Head , Rare Diseases , Orphan Drugs , Pediatric Rare Disease Studies , Life Science , Press Release ,